FIPRecover Biotechnology is launching a dedicated Veterinary Partnership Program, aimed at providing veterinary clinics with comprehensive resources for managing FIP cases.
Recognizing the critical role of veterinarians, this initiative will offer detailed therapeutic guidelines, access to the latest clinical data on GS441524 and Molnupiravir, and direct technical support. “We believe that a collaborative approach is key to successful outcomes,” the company stated. “By equipping veterinary professionals with reliable medications and robust support, we build a stronger defense against FIP, directly supporting our mission to alleviate suffering and promote recovery.”
Post Comment